Peter Boström

Impact of asymptomatic bacteriuria on the outcomes and tolerability of Bacillus Calmette–Guérin immunotherapy (2026)

Scandinavian Journal of Urology

Nummi, Antti; Nurminen, Pertti; Kesti, Olli; Högerman, Mikael; Ettala, Otto; Boström, Peter J.; Kaipia, Antti; Sairanen, Jukka; Järvinen, Riikka

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Can Radiomics Based Models Survive Across MRI Scanners? (2026)

Lecture Notes in Networks and Systems

Chaudhary, Jatin; Jambor, Ivan; Aronen, Hannu; Ettala, Otto; Saunavaara, Jani; Boström, Peter; Heikkonen, Jukka; Kanth, Rajeev; Merisaari, Harri

(A4 Vertaisarvioitu artikkeli konferenssijulkaisussa)

Radical cystectomy practice patterns in the Nordic countries: results from the prospective NorCys study (2026)

Scandinavian Journal of Urology

Venhomaa, Tiia; Nikulainen, Ilkka; Bobjer, Johannes; Bläckberg, Mats; Bro, Lasse; Brandt, Simone Buchardt; Ettala, Otto; Fabrin, Knud; Gudjonsson, Sigurdur; Haug, Erik Skaaheim; Högerman, Mikael; Hyldgaard, Josephine M.; Jerlström, Tomas; Kirrander, Peter; Koskinen, Ilmari; Lam, Gitte; Leskinen, Markku J.; Liedberg, Fredrik; Livbjerg, Astrid Helene; Seikkula, Heikki; Skovhus, Katharina; Ströck, Viveka; Tuckus, Grazvydas; Virta, Ville; Vrang, Marie-Louise; Jensen, Jørgen Bjerggaard; Boström, Peter J.

(A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä)

Aberrantly glycosylated PSMA in urine as a potential marker for prostate cancer (2026)

Clinica Chimica Acta

Khan, Misba; Islam, Md. Khirul; Taimen, Pekka; Boström, Peter J.; Lamminmäki, Urpo; Leivo, Janne

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic obstruction: 1-year clinical outcomes of a phase II study (2025)

BJU International

Viitala, Antti; Anttinen, Mikael; Mäkelä, Pietari; Pärssinen, Heikki; Nurminen, Pertti; Sainio, Teija; Saunavaara, Jani; Taimen, Pekka; Sequeiros, Roberto Blanco; Boström, Peter J.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Long‐Term Risk of Clinically Significant Prostate Cancer in Biopsy‐Negative Patients With Baseline Biparametric Prostate MRI (2025)

Journal of Magnetic Resonance Imaging

Parhiala, Laura; Knaapila, Juha; Jambor, Ivan; Verho, Janne; Syvänen, Kari; Aronen, Hannu; Boström, Peter; Ettala, Otto

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Improved diagnostic performance of a phage display antibody-assisted intact free PSA assay as used in the four kallikrein concept applied to the IMPROD/multi-IMPROD study (2025)

Clinica Chimica Acta

Khan, Md. Ferdhos L.; Perez, Ileana M.; Kekki, Henna; Taimen, Pekka; Boström, Peter J.; Jambor, Ivan; Ettala, Otto; Pahikkala, Tapio; Pettersson, Kim

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Time to abandon routine urine analysis prior to Bacillus Calmette–Guérin administration in asymptomatic patients (2025)

BJUI COMPASS

Nummi, Antti; Nurminen, Pertti; Kesti, Olli; Högerman, Mikael; Ettala, Otto; Boström, Peter J.; Kaipia, Antti; Sairanen, Jukka; Järvinen, Riikka

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer (2025)

European Urology Open Science

Anttinen, Mikael; Mäkelä, Pietari; Nurminen, Pertti; Pärssinen, Heikki; Malaspina, Simona; Sainio, Teija; Högerman, Mikael; Taimen, Pekka; Blanco Sequeiros, Roberto; Boström, Peter J.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Prospective comparison of 18F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancer (2025)

European Journal of Nuclear Medicine and Molecular Imaging

Kivikallio, Aino; Malaspina, Simona; Saarinen, Irena; Seppänen, Marko; Anttinen, Mikael; Jambor, Ivan; Verho, Janne; Kemppainen, Jukka; Aronen, Hannu J.; Boström, Peter J.; Ettala, Otto; Taimen, Pekka

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Peter

Boström

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Impact of asymptomatic bacteriuria on the outcomes and tolerability of Bacillus Calmette–Guérin immunotherapy (2026)

Can Radiomics Based Models Survive Across MRI Scanners? (2026)

Radical cystectomy practice patterns in the Nordic countries: results from the prospective NorCys study (2026)

Aberrantly glycosylated PSMA in urine as a potential marker for prostate cancer (2026)

Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic obstruction: 1-year clinical outcomes of a phase II study (2025)

Long‐Term Risk of Clinically Significant Prostate Cancer in Biopsy‐Negative Patients With Baseline Biparametric Prostate MRI (2025)

Improved diagnostic performance of a phage display antibody-assisted intact free PSA assay as used in the four kallikrein concept applied to the IMPROD/multi-IMPROD study (2025)

Time to abandon routine urine analysis prior to Bacillus Calmette–Guérin administration in asymptomatic patients (2025)

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer (2025)

Prospective comparison of 18F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancer (2025)